|
Real-time Estimate
Cboe BZX
22:34:19 26/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.595 USD | -4.49% |
|
0.00% | -81.51% |
| 10-15 | EnGene Therapeutics Inc. - Special Call | |
| 09-21 | EnGene Therapeutics Inc.(NasdaqCM:ENGN) dropped from S&P Global BMI Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 105M | - | - | - | - | - |
| 64.69B | |||||
| 54.78B | |||||
| 53.49B | |||||
| 45.98B | |||||
| 42.94B |
Select your edition
All financial news and data tailored to specific country editions
